Valomaciclovir Stearate

N/A

Report date: 2022/12/07 18:09:29
NME

Base Information

Drug NameValomaciclovir Stearate
Drug Alias Namevalomaciclovirum伐马洛韦硬脂酸盐EPB-348A-174606.0ABT-606 +[7] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHuman herpesvirus 1 DNA polymerase inhibitorsHuman herpesvirus 5 DNA polymerase inhibitors
TargetsHuman herpesvirus 1 DNA polymeraseHuman herpesvirus 5 DNA polymerase
Therapy Area/IndicationsHerpes ZosterInfectious Mononucleosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedivir AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedivir ABUniversity Of MinnesotaEpiphany Biosciences Inc
Active IndicationsN/A
Inactive IndicationsHerpes ZosterInfectious Mononucleosis

Other Information

ATC CodeN/A
Related LinksKEGG